	FDG-PET
Neoadjuvant chemotherapy
Colorectal liver metastases
	neoadjuvant chemotherapy
lesions
patients
FDG-PET
extrahepatic disease
neoadjuvant treatment
chemotherapy
triphasic contrast-enhanced CT
abdominal CT
liver
sensitivity
Staging
detection
metastases
nonresectable disease
metastatic sites
hepatic resection
extensive extrahepatic disease
survival rates
original imaging findings
tumor
imaging results
pathological findings
Longer follow-up
resection
results
high risk
standard deviation 19
response rates
treatment
higher
bevacizumab
recurrence
colorectal
neoadjuvant

